Vor Biopharma (VOR) Competitors

180 Life Sciences (NASDAQ:ATNFW) and Vor Biopharma (NASDAQ:VOR) are both pharmaceutical products companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, risk, analyst recommendations, valuation, institutional ownership, profitability and media sentiment.

Which has higher valuation and earnings, ATNFW or VOR?

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
180 Life Sciences	N/A	N/A	N/A	N/A	N/A
Vor Biopharma	N/A	N/A	N/A	-$1.51	-0.70

Is ATNFW or VOR more profitable?

Company	Net Margins	Return on Equity	Return on Assets
180 Life Sciences	N/A	N/A	N/A
Vor Biopharma	N/A	N/A	N/A

Does the media favor ATNFW or VOR?

In the previous week, Vor Biopharma had 1 more articles in the media than 180 Life Sciences. MarketBeat recorded 2 mentions for Vor Biopharma and 1 mentions for 180 Life Sciences. 180 Life Sciences' average media sentiment score of 1.87 beat Vor Biopharma's score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the media.

Company	Overall Sentiment
180 Life Sciences	Very Positive
Vor Biopharma	Neutral

Do institutionals & insiders believe in ATNFW or VOR?

97.3% of Vor Biopharma shares are owned by institutional investors. 2.9% of Vor Biopharma shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Vor Biopharma beats 180 Life Sciences on 3 of the 4 factors compared between the two stocks.